Platelet aggregation in dogs with mitral valve regurgitation

Area of Science:

• Veterinary Cardiology
• Hematology
• Canine Health

Background:

• Mitral valve regurgitation (MVR) is a common cardiac condition in dogs.
• Platelet function plays a crucial role in cardiovascular health and disease.
• The impact of MVR on canine platelet function remains incompletely understood.

Purpose of the Study:

• To investigate and compare platelet aggregation in dogs with MVR versus healthy controls.
• To determine if MVR influences platelet function, specifically maximum aggregation and enhancement of platelet sensitivity (EPS).

Main Methods:

• Platelet aggregation was assessed using an aggregometer with adenosine 5'-diphosphate as the stimulus.
• Measurements included maximum aggregation and enhancement of platelet sensitivity (EPS) values.
• The study included 32 dogs with MVR and 43 healthy dogs, with MVR dogs further classified by New York Heart Association functional class.

Main Results:

• No significant differences were found in platelet count or maximum aggregation between MVR and healthy dogs.
• Dogs with MVR exhibited significantly higher EPS values compared to healthy controls.
• Higher functional class MVR dogs (III-IV) showed significantly higher EPS values than lower functional class dogs (I-II).

Conclusions:

• Platelet aggregation dynamics are altered in dogs with MVR.
• Enhancement of platelet sensitivity (EPS) is a more sensitive indicator of MVR disease severity than maximum aggregation.
• EPS may serve as a valuable biomarker for assessing MVR progression in dogs.